Related Experiment Videos
Transfer factor: Potential for therapy of malignant diseases
Archives of Otolaryngology (Chicago, Ill. : 1960)
|November 1, 1975
Summary
Transfer factor (TF) therapy shows promise for treating cancers. This leukocyte extract transfers immunity and has low toxicity, prompting clinical trials in malignant diseases as potential adjuvant treatment.
Area of Science:
- Immunology
- Oncology
- Cellular Biology
Background:
- Transfer factor (TF) is a leukocyte extract that transfers cell-mediated immunity.
- TF has demonstrated efficacy in immunodeficiency and infectious diseases with low toxicity.
- Clinical trials are exploring TF therapy for human malignant diseases.
Purpose of the Study:
- To investigate the potential role of transfer factor (TF) as an adjuvant therapy in human malignant neoplasms.
- To explore variables influencing TF efficacy, including donor/patient selection, dosage, and concurrent therapies.
Main Methods:
- The abstract does not specify the methods used in the clinical trials.
- Focus is on preliminary reports and exploration of variables.
Main Results:
- Preliminary reports suggest potential efficacy of TF therapy in malignant diseases.
- TF has shown a lack of toxicity in previous studies.
Conclusions:
- Transfer factor (TF) may serve as an effective adjuvant therapy for human malignant neoplasms.
- Further research is needed to optimize TF therapy by exploring key variables.